Niemann Pick C (NPC), a fatal autosomal-recessive neurovisceral lipid storage disorder, is a juvenile dementia with massive nerve-cell loss and cytoskeletal abnormalities in cerebral neurons. These abnormalities consist of tangles of tau protein, which is otherwise highly soluble and usually stabilizes the microtubules. Immunologically and ultrastructurally similar tangles are seen some decades later in patients with Alzheimer’s disease (AD). There is evidence that tangle-bearing cells in both diseases show higher levels of free (i. e. filipin-positive) cholesterol than adjacent tangle-free nerve cells. The cholesterol accumulates either in a more diffuse way (mainly in AD) or in granule-like accumulations (mainly in NPC). In NPC, neuron cholesterol may originate from sources other than the alimentary tract. Experiments with a NPC mouse model revealed that even in pure neuron cultures, the NPC -/- neurons accumulate free cholesterol in contrast to NPC-wt littermates, suggesting that the cholesterol is either synthesized by the neurons or liberated from degenerated ones before being taken up by the endosomal/lysosomal pathway. The accumulation of free cholesterol in the somata of NPC neurons is associated with a decrease of cholesterol levels in myelin sheaths. In terms of tau protein, NPC -/- mice exhibit higher levels of AT8-positive tau, suggesting that the phosphorylation-dependent mAb AT8 has detected a tau-epitope in a state considered to represent early stages of tangle formation. Concomitantly to the increase in free intracellular cholesterol, the rate-limiting enzyme in cholesterol and isoprenoid biosynthesis, HMG-CoA reductase, was found to be significantly reduced. Experimental blockade of the enzyme’s activity by application of the lipid-lowering drug lovastatin showed subcellular shifts in tau phosphorylation as monitored with mAbs AT8, 12E8 and others. In summary, the data showed interesting similarities between NPC and AD suggesting some pathological metabolic pathway in common.
References
-
1
Arendt T, Schindler C, Brückner M K, Eschrich K, Bigl V, Zedlick D. et al .
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein e4 allele.
J Neurosci.
1997;
17(2)
516-529
-
2
Auer I A, Schmidt M L, Lee V M, Curry B, Suzuki K, Shin R W. et al .
Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease.
Acta Neuropathol (Berl).
1995;
90(6)
547-551
-
3
Braak E, Braak H, Mandelkow E M.
A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.
Acta Neuropathol (Berl).
1994;
87(6)
54-567
-
4
Braak H, Braak E.
Neuropathological stageing of Alzheimer-related changes.
Acta Neuropathol (Berl).
1991;
82(4)
239-259
-
5
Braak H, Braak E, Grundke-Iqbal I, Iqbal K.
Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques.
Neurosci Lett.
1986;
65
351-355
-
6 Braak H, Duyckaerts C, Braak E, Piette F. Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, editors Alzheimer's Disease: Advances in Clinical and Basic Research. John Wiley & Sons Ltd 1993: 131-137
-
7
Brown M S, Herz J, Goldstein J L.
LDL-receptor structure. Calcium cages, acid baths and recycling receptors.
Nature.
1997;
388(6634)
629-630
-
8
Carstea E D, Morris J A, Coleman K G, Loftus S K, Zhang D, Cummings C. et al .
Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis.
Science.
1997;
277
288-231
-
9
Corder E H, Saunders A M, Strittmatter W J, Schmechel D E, Gaskell P, Small G W. et al .
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Science.
1993;
261(5123)
921-923
-
10
Distl R, Meske V, Ohm T G.
Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons.
Acta Neuropathol (Berl).
2001;
101
547-554
-
11 Distl R, Treiber-Held S, Albert F, Meske V, Harzer K, and Ohm T G. Cholesterol storage and tau-pathology in Niemann-Pick type C disease brain. J Pathol 2002 (In Press)
-
12
Gärtner U, Holzer M, Heumann R, Arendt T.
Induction of p21ras in Alzheimer pathology.
Neuroreport.
1997;
6(10)
1441-1444
-
13
Glöckner F, Meske V, Ohm T G.
Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
Neuroscience.
2002;
114(4)
1103-1114
-
14
Jick H, Zornberg G L, Jick S S, Seshadri S, Drachman D A.
Statins and the risk of dementia.
Lancet.
2000;
356(9242)
1627-1631
-
15
Love S, Bridges L R, Case C P.
Neurofibrillary tangles in Niemann-Pick disease type C.
Brain.
1995;
118(Pt 1)
119-129
-
16
Meske V.
Albert F, Ohm TG. Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation. Implications for Alzheimer's disease.
Eur J Neurosci.
2003;
17(1)
93-102
-
17
Meske V, Treiber-Held S, Tamannai M, Ohm T G.
Increased intraneuronal free cholesterol is associated with reduced HMG-COA-reducase and increased AT-8 epitope of tau-protein.
Neurobiol Aging.
2002;
23(1S)
S502
-
18
Naureckiene S, Sleat D E, Lackland H, Fensom A, Vanier M T, Wattiaux R. et al .
Identification of HE1 as the second gene of Niemann-Pick C disease.
Science.
2000;
290(5500)
2298-2301
-
19
Ohm T G, Muller H, Braak H, Bohl J.
Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.
Neuroscience.
1995;
64(1)
209-217
-
20
Ohm T G, Scharnagl H, Marz W, Bohl J.
Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Acta Neuropathol (Berl).
1999;
98(3)
273-280
-
21
Poirier J, Hess M, May P C, Finch C E.
Astrocytic apolipoprotein-E messenger RNA and GFAP messenger RNA in hippocampus after entorhinal cortex lesioning.
Mol Brain Res.
1991;
11
97-106
-
22
Poirier J, Minnich A, Davignon J.
Apolipoprotein E, synaptic plasticity and Alzheimer's disease.
Ann Med.
1995;
27(6)
663-670
-
23 Price J L. Tangles and plaques in healthy aging and Alzheimer's disease: Independence or interaction. Semin Neurosci 1994: 395-402
-
24
Price J L, Morris J C.
Tangles and plaques in nondemented aging and ”preclinical” Alzheimer's disease.
Ann Neurol.
1999;
45(3)
358-368
-
25
Saito Y, Suzuki K, Nanba E, Yamamoto T, Ohno K, Murayama S.
Niemann-Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon4 homozygosity.
Ann Neurol.
2002;
52
351-355
-
26
Simons M, Keller P, De Strooper B, Beyreuther K, Dotti C G, Simons K.
Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.
Proc Natl Acad Sci U S A.
1998;
95(11)
6460-6464
-
27
Suzuki K, Parker C C, Pentchev P G, Katz D, Ghetti B, D'Agostino A. et al .
Neurofibrillary tangles in Niemann-Pick disease type C.
Acta Neuropathol Berl.
1995;
89(3)
227-238
-
28
Treiber-Held S, Distl R, Albert F, Ohm T G.
Spatial and temporal distribution of free cholesterol on single cell level in brain of a Niemann Pick type C mouse model.
J Pathol.
2003;
200
95-103
-
29
Vanier M T, Suzuki K.
Recent advances in elucidating Niemann-Pick C disease.
Brain Pathol.
1998;
8(1)
163-174
-
30
Wolozin B, Kellman W, Ruosseau P, Celesia G G, Siegel G.
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
Arch Neurol.
2000;
57(10)
1439-1443
-
31
Xie C, Burns D K, Turley S D, Dietschy J M.
Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased.
J Neuropathol Exp Neurol.
2000;
59(12)
1106-1117
-
32
Zervas M, Dobrenis K, Walkley S U.
Neurons in Niemann-Pick Disease Type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations.
J Neuropathol Exp Neurol.
2001;
60
49-64
Thomas G. Ohm
Institute of Anatomy
Department of Clinical Cell- and Neurobiology
Charité
10098 Berlin
Germany
Phone: +49-30-450-528202
Fax: +49-30-450-528913
Email: thomas_georg.ohm@charite.de
